<DOC>
	<DOCNO>NCT02769273</DOCNO>
	<brief_summary>Prospective , international , multi-center , single arm , observational study continue assess treatment Stellarex™ OTW Drug-coated Angioplasty Balloon superficial femoral and/or popliteal artery accord Instructions Use broad , real-world , claudicant ischemic rest pain patient population per institution 's standard practice .</brief_summary>
	<brief_title>Stellarex Vascular E-Registry</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Patients intend treated Stellarex denovo restenotic lesion femoropopliteal artery Rutherford Clinical Category ( RCC ) 23 4 indicate Percutaneous Transluminal Angioplasty accord local applicable guideline Age ≥18 year old Life expectancy &gt; 1 year Is able willing provide write informed consent prior enrollment study ( applicable ) Is able willing come site contact phone followup Patients medical condition would make him/her inappropriate treatment Stellarex per Instructions Use ( IFU ) investigator 's opinion Patient already enrol investigational ( interventional ) study would interfere study endpoint Patients judgment investigator would need treatment knee and/or index procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>